Literature DB >> 28270531

Principles of Reconstructing the Subclonal Architecture of Cancers.

Stefan C Dentro1,2, David C Wedge3, Peter Van Loo2,4.   

Abstract

Most cancers evolve from a single founder cell through a series of clonal expansions that are driven by somatic mutations. These clonal expansions can lead to several coexisting subclones sharing subsets of mutations. Analysis of massively parallel sequencing data can infer a tumor's subclonal composition through the identification of populations of cells with shared mutations. We describe the principles that underlie subclonal reconstruction through single nucleotide variants (SNVs) or copy number alterations (CNAs) from bulk or single-cell sequencing. These principles include estimating the fraction of tumor cells for SNVs and CNAs, performing clustering of SNVs from single- and multisample cases, and single-cell sequencing. The application of subclonal reconstruction methods is providing key insights into tumor evolution, identifying subclonal driver mutations, patterns of parallel evolution and differences in mutational signatures between cellular populations, and characterizing the mechanisms of therapy resistance, spread, and metastasis.
Copyright © 2017 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28270531      PMCID: PMC5538405          DOI: 10.1101/cshperspect.a026625

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  33 in total

1.  Reconstructing tumor evolutionary histories and clone trees in polynomial-time with SubMARine.

Authors:  Linda K Sundermann; Jeff Wintersinger; Gunnar Rätsch; Jens Stoye; Quaid Morris
Journal:  PLoS Comput Biol       Date:  2021-01-19       Impact factor: 4.475

2.  Transient expansion of TP53 mutated clones in polycythemia vera patients treated with idasanutlin.

Authors:  Bridget K Marcellino; Noushin Farnoud; Bruno Cassinat; Min Lu; Emanuelle Verger; Erin McGovern; Minal Patel; Juan Medina-Martinez; Max Fine Levine; Juanes E Arango Ossa; Yangyu Zhou; Heidi Kosiorek; Meenakshi Mehrotra; Jane Houldsworth; Amylou Dueck; Michael Rossi; John Mascarenhas; Jean-Jacques Kiladjian; Raajit K Rampal; Ronald Hoffman
Journal:  Blood Adv       Date:  2020-11-24

3.  PhyDOSE: Design of follow-up single-cell sequencing experiments of tumors.

Authors:  Leah L Weber; Nuraini Aguse; Nicholas Chia; Mohammed El-Kebir
Journal:  PLoS Comput Biol       Date:  2020-10-01       Impact factor: 4.475

4.  Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor.

Authors:  Justin Taylor; Mark Ta Donoghue; Caleb Ho; Kseniya Petrova-Drus; Hikmat A Al-Ahmadie; Samuel A Funt; Yanming Zhang; Umut Aypar; Pavitra Rao; Shweta S Chavan; Michael Haddadin; Roni Tamari; Sergio Giralt; Martin S Tallman; Raajit K Rampal; Priscilla Baez; Rajya Kappagantula; Satyajit Kosuri; Ahmet Dogan; Satish K Tickoo; Victor E Reuter; George J Bosl; Christine A Iacobuzio-Donahue; David B Solit; Barry S Taylor; Darren R Feldman; Omar Abdel-Wahab
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

5.  Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes.

Authors:  Stefan C Dentro; Ignaty Leshchiner; Kerstin Haase; Maxime Tarabichi; Jeff Wintersinger; Amit G Deshwar; Kaixian Yu; Yulia Rubanova; Geoff Macintyre; Jonas Demeulemeester; Ignacio Vázquez-García; Kortine Kleinheinz; Dimitri G Livitz; Salem Malikic; Nilgun Donmez; Subhajit Sengupta; Pavana Anur; Clemency Jolly; Marek Cmero; Daniel Rosebrock; Steven E Schumacher; Yu Fan; Matthew Fittall; Ruben M Drews; Xiaotong Yao; Thomas B K Watkins; Juhee Lee; Matthias Schlesner; Hongtu Zhu; David J Adams; Nicholas McGranahan; Charles Swanton; Gad Getz; Paul C Boutros; Marcin Imielinski; Rameen Beroukhim; S Cenk Sahinalp; Yuan Ji; Martin Peifer; Inigo Martincorena; Florian Markowetz; Ville Mustonen; Ke Yuan; Moritz Gerstung; Paul T Spellman; Wenyi Wang; Quaid D Morris; David C Wedge; Peter Van Loo
Journal:  Cell       Date:  2021-04-07       Impact factor: 41.582

Review 6.  Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes.

Authors:  Joshua J Meeks; Hikmat Al-Ahmadie; Bishoy M Faltas; John A Taylor; Thomas W Flaig; David J DeGraff; Emil Christensen; Benjamin L Woolbright; David J McConkey; Lars Dyrskjøt
Journal:  Nat Rev Urol       Date:  2020-03-31       Impact factor: 14.432

7.  Tracing the evolution of aneuploid cancers by multiregional sequencing with CRUST.

Authors:  Subhayan Chattopadhyay; Jenny Karlsson; Anders Valind; Natalie Andersson; David Gisselsson
Journal:  Brief Bioinform       Date:  2021-11-05       Impact factor: 11.622

Review 8.  Leveraging Single-Cell Approaches in Cancer Precision Medicine.

Authors:  Aritro Nath; Andrea H Bild
Journal:  Trends Cancer       Date:  2021-02-06

Review 9.  A practical guide to cancer subclonal reconstruction from DNA sequencing.

Authors:  Maxime Tarabichi; Adriana Salcedo; Amit G Deshwar; Máire Ni Leathlobhair; Jeff Wintersinger; David C Wedge; Peter Van Loo; Quaid D Morris; Paul C Boutros
Journal:  Nat Methods       Date:  2021-01-04       Impact factor: 28.547

Review 10.  Decoding human cancer with whole genome sequencing: a review of PCAWG Project studies published in February 2020.

Authors:  Simona Giunta
Journal:  Cancer Metastasis Rev       Date:  2021-06-07       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.